Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Feb 17, 2015 · 10-Q · 48 days after period end · 0001062993-15-000906
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$786.72K | $358.64K | -$453.52K | -$2.17M |
| EPS Diluted | -$0.06 | -$0.01 | -$0.01 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Feb 17, 2015 · 48 d after period end
